FUTURA MEDICAL PLC Logo

FUTURA MEDICAL PLC

FUM | IL

Overview

Corporate Details

ISIN(s):
GB0033278473
LEI:
21380053QLT46UNV2303
Country:
United Kingdom
Address:
Surrey Technology Centre, GU2 7YG Guildford
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Futura Medical PLC is a pharmaceutical company specializing in the research, development, and global commercialization of innovative sexual health products. The company's core expertise lies in topically delivered gel formulations. Its lead product is Eroxon®, a clinically proven, fast-acting topical treatment for erectile dysfunction (ED) that is available over-the-counter (OTC) without a prescription in major markets, including the USA and Europe. Futura Medical operates a de-risked business model by partnering with established consumer healthcare companies for marketing and distribution. The company's development pipeline includes product extensions and potential treatments for female sexual dysfunction.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for FUTURA MEDICAL PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-08 08:00
Board/Management Information
Board Changes, Business Update & Notice of Results
English 23.1 KB
2025-07-11 12:04
Regulatory News Service
Share price movement
English 11.1 KB
2025-06-20 08:00
Post-Annual General Meeting Information
Result of AGM
English 30.7 KB
2025-06-02 16:15
Regulatory News Service
Block Listing Six Monthly Return
English 18.5 KB
2025-05-27 08:00
Pre-Annual General Meeting Information
Notice of AGM and availability of Annual Report
English 15.9 KB
2025-03-31 08:00
Board/Management Information
Board Appointment
English 18.2 KB
2025-01-30 08:00
Business and Financial Review
FY24 Trading Update and FY25 Outlook
English 28.3 KB
2025-01-13 08:00
Remuneration Information
Remuneration of Non-Executive Directors and TVR's
English 48.6 KB
2024-12-20 08:58
Major Shareholding Notification
Holding(s) in Company
English 52.6 KB
2024-12-02 08:00
Regulatory News Service
Block Listing Six Monthly Return
English 19.6 KB
2024-11-15 08:00
Major Shareholding Notification
TR-1: Notification of major holdings
English 52.6 KB
2024-11-04 08:00
Earnings Release
Encouraging New Product Development Pipeline
English 21.5 KB
2024-10-31 08:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 12.2 KB
2024-10-17 15:00
Regulatory News Service
Clinical trial data presented at SMSNA
English 15.8 KB
2024-10-07 08:00
Earnings Release
Further milestone payment triggered post US launch
English 12.0 KB

Automate Your Workflow. Get a real-time feed of all FUTURA MEDICAL PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for FUTURA MEDICAL PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Spago Nanomedical AB Logo
Develops nanomedicine for precision MRI tumor diagnostics and targeted cancer radionuclide therapy.
Sweden SPAGO
Spexis AG Logo
Developing first-in-class macrocyclic drugs for rare diseases and oncology.
Switzerland SPEX
Sprint Bioscience Logo
Develops and out-licenses preclinical cancer drug programs using fragment-based discovery.
Sweden SPRINT
Stayble Therapeutics AB Logo
Develops an injectable therapy for disc-related spinal disorders as an alternative to surgery.
Sweden STABL
Stem Cells Spin Spolka Akcyjna Logo
Commercializes patented MIC-1 stem cell technology for regenerative medicine.
Poland SCS
STRIX GROUP PLC Logo Isle of Man KETL
SynAct Pharma Logo
Developing oral resolution therapies for inflammatory diseases like rheumatoid arthritis.
Sweden SYNACT
SYNAIRGEN PLC Logo
Develops an inhaled interferon beta therapy for severe viral lung infections.
United Kingdom SNG
Terranet B Logo
Develops ultra-fast ADAS anti-collision technology for automakers to protect vulnerable road users.
Sweden TERRNT
Israel TMIS